CLINICAL_TRIALS
trial_result
· 2016-03-01
Clinical Trial Update: Selexipag (ACT-293987) in Pulmonary Arterial Hypertension [Phase 3]
Summary
A Phase 3 trial evaluating selexipag for pulmonary arterial hypertension has completed and results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2016-03-01